Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07588243 · ClinicalTrials.gov registry record · NA
A Clinical Study to Evaluate the Efficacy and Safety of Ultra in Promoting Hair Regrowth
A NA study, sponsored by CynosureLutronic.
- Recruiting
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT07588243: Recruiting NA study, sponsored by CynosureLutronic.
NCT07588243 is a NA study that is actively recruiting participants, run by CynosureLutronic. The registered enrollment target is 44 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07588243, a NA study, is actively recruiting participants, sponsored by CynosureLutronic.
- RECRUITING
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
The goal of this clinical study is to evaluate the efficacy and safety of the Ultra device for the treatment of hair regrowth by assessing the improvement of hair density and hair shaft diameter.
Primary Outcome
To evaluate the difference in the change in hair density at baseline vs 90 day follow up in a pre-determined measurement point in the treatment area as measured with a professional dermascope.
Interventions
- DEVICE Low Level Laser Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2026-02-19 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT07588243 shows while recruiting
NCT07588243 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Low Level Laser Therapy is the first listed.
NCT07588243 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07588243 about?
NCT07588243 is a clinical study titled "A Clinical Study to Evaluate the Efficacy and Safety of Ultra in Promoting Hair Regrowth". The goal of this clinical study is to evaluate the efficacy and safety of the Ultra device for the treatment of hair regrowth by assessing the improvement of hair density and hair shaft diameter.
What is the current status of trial NCT07588243?
This trial is currently recruiting. It is a NA study. The enrollment target is 44 participants. The study started on 2026-02-19. Estimated completion is 2026-12.
What interventions are being tested in trial NCT07588243?
The interventions under investigation include: Low Level Laser Therapy (DEVICE).
Who is sponsoring clinical trial NCT07588243?
This trial is sponsored by CynosureLutronic, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07588243's enrollment target sits among peer trials
44 1423rd of 2000 higher than 566 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI